Nanotechnology in vaccine development: a step forward

scientific article published in May 2009

Nanotechnology in vaccine development: a step forward is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/JID.2009.63
P698PubMed publication ID19369930
P5875ResearchGate publication ID24280982

P2093author name stringAdnan Nasir
P2860cites workPrinciples for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyQ21223673
The Genome of the African Trypanosome Trypanosoma bruceiQ22065798
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?Q24652185
The Dalila effect: C57BL6 mice barber whiskers by pluckingQ28145078
In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVRQ28290077
Toxic potential of materials at the nanolevelQ28295314
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skinQ28307179
Comparative genomics of trypanosomatid parasitic protozoaQ29617953
Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshopQ33285010
Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extractionQ33293584
Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptakeQ33358882
Antiviral prophylaxis of smallpoxQ34323056
Viral infections in atopic dermatitis Pathogenic aspects and clinical managementQ35562168
Requirements for Th1-dependent immunity against infection with Leishmania majorQ35893834
The effect of particle design on cellular internalization pathwaysQ36954579
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cellsQ40179067
Dermatologic toxicity of nanoengineered materialsQ47905517
Sequences of two kinetoplast minicircle DNAs of Trypanosoma (Nannomonas) congolenseQ48342282
Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.Q50610735
Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growthQ56908091
Increasing incidence of eczema herpeticum: analysis of seventy-five casesQ67990603
Transcutaneous immunization: a human vaccine delivery strategy using a patchQ73252637
Characterization of the altered cutaneous reactivity of transgenic mice whose keratinocytes overexpress B7-1Q74475027
B7-1 overexpression by thymic epithelial cells results in transient and long-lasting effects on thymocytes and peripheral T helper cells but does not result in immunodeficiencyQ77928232
AIDS research. Did Merck's failed HIV vaccine cause harm?Q79843419
Antigenic targeting of the human mannose receptor induces tumor immunityQ80257353
Dose sparing with intradermal injection of influenza vaccineQ80961566
Molluscum contagiosum in Greek children: a case seriesQ81609087
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectnanotechnologyQ11468
P304page(s)1055-1059
P577publication date2009-05-01
P1433published inJournal of Investigative DermatologyQ3186921
P1476titleNanotechnology in vaccine development: a step forward
P478volume129

Reverse relations

cites work (P2860)
Q24170384Applications of nanotechnology in dermatology
Q38074461Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers.
Q36925868Nanomaterials in the application of tumor vaccines: advantages and disadvantages
Q38813137Plague Vaccines: Status and Future
Q40425661Plasmid pVAX1-NH36 purification by membrane and bead perfusion chromatography
Q41628326Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production
Q43477258Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses
Q37820669Towards a Chlamydia trachomatis vaccine: how close are we?
Q39390000Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals
Q38105343Viral vaccines for bony fish: past, present and future.

Search more.